Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

1. Agache, I.
2. Rocha, C.
3. Beltran, J.
4. Song, Y.
5. Posso, M.
6. Solà, I.
7. Alonso-Coello, P.
8. Akdis, C.
9. Akdis, M.
10. Canonica, G.W.
11. Casale, T.
12. Chivato, T.
13. Corren, J.
14. Del Giacco, S.
15. Eiwegger, T.
16. Firinu, D.
17. Gern, J.E.
18. Hamelmann, E.
19. Hanania, N.
20. Mäkelä, M.
21. Martín, I.H.
22. Nair, P.
23. O'Mahony, L.
24. Papadopoulos, N.G.
25. Papi, A.
26. Park, H.-S.
27. Pérez de Llano, L.
28. Quirce, S.
29. Sastre, J.
30. Shamji, M.
31. Schwarze, J.
32. Canelo-Aybar, C.
33. Palomares, O.
34. Jutel, M.
35. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/ALL.14235 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus